trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'breast', 'destiny-breast04']
dr shanu modi updates ecancer at #asco22 on the destiny-breast04 trial: trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression 
ecancer is a charity with a mission to raise the standards of care for cancer patients across the world through education. #openaccess